Skip to main content
Signal8

Furney Natalie Anne Marie

SEC insider (Form 3/4/5 filer). CIK 0002111535. Global General Counsel at TAKEDA PHARMACEUTICAL CO LTD (TAK). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in CAMBRIDGE, MA.

Companies Furney Natalie Anne Marie has filed insider reports for

  • TAKEDA PHARMACEUTICAL CO LTD (TAK): Officer, Global General Counsel
Furney Natalie Anne Marie profile photo

Furney Natalie Anne Marie

CIK: 0002111535

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TAKEDA PHARMACEUTICAL CO LTD logo
TAK

TAKEDA PHARMACEUTICAL CO LTD

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Aug 10, 2026
    Sale
    Direct
    30.9K shares at avg. $17.10$528K
  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Jul 1, 2026
    Award
    Direct
    43.9K shares-

1-2 of 2